Literature DB >> 16291992

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.

Thomas Carpenter, Michael E Trautmann, Alain D Baron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16291992     DOI： 10.1056/NEJM200511173532017

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

2.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03

3.  Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.

Authors:  Blandine Laferrère; Stanley Heshka; Krystle Wang; Yasmin Khan; James McGinty; Julio Teixeira; Allison B Hart; Blanca Olivan
Journal:  Diabetes Care       Date:  2007-04-06       Impact factor: 19.112

4.  Protocol for a randomised clinical study comparing the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on reactive hypoglycaemia in morbidly obese subjects.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Marco Raffaelli; Cosimo Callari; Pio Celestino Lombardi; Rocco Bellantone
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

5.  Tissue-specific effects of bariatric surgery including mitochondrial function.

Authors:  Simon N Dankel; Vidar Staalesen; Bodil Bjørndal; Rolf K Berge; Gunnar Mellgren; Lena Burri
Journal:  J Obes       Date:  2011-01-12

6.  A simple matter of life and death-the trials of postnatal Beta-cell mass regulation.

Authors:  Elena Tarabra; Stella Pelengaris; Michael Khan
Journal:  Int J Endocrinol       Date:  2012-04-22       Impact factor: 3.257

7.  Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.

Authors:  Aleksey V Matveyenko; Sarah Dry; Heather I Cox; Artemis Moshtaghian; Tatyana Gurlo; Ryan Galasso; Alexandra E Butler; Peter C Butler
Journal:  Diabetes       Date:  2009-04-29       Impact factor: 9.461
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.